Celon Pharma S.A. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported revenue was PLN 68.95 million compared to PLN 52.83 million a year ago. Net income was PLN 9.14 million compared to net loss of PLN 8.11 million a year ago. Basic earnings per share from continuing operations was PLN 0.18. Diluted earnings per share from continuing operations was PLN 0.18.
For the six months, revenue was PLN 112.84 million compared to PLN 94.76 million a year ago. Net loss was PLN 6.34 million compared to PLN 15.62 million a year ago. Basic loss per share from continuing operations was PLN 0.12 compared to PLN 0.31 a year ago. Diluted loss per share from continuing operations was PLN 0.12 compared to PLN 0.31 a year ago.